Differences between basal lung levels of select eicosanoids in rat and mouse

Area of Science:

• Biochemistry
• Pulmonary Medicine
• Pharmacology

Background:

• Arachidonic acid metabolites are crucial mediators of inflammation, cell proliferation, and oxidative stress, implicated in various pulmonary diseases.
• Significant interspecies differences exist in responses to experimental pulmonary hypertensive stimuli between rats and mice.

Purpose of the Study:

• To investigate if differences in basal eicosanoid profiles between rats and mice correlate with their varying responses to pulmonary hypertension.
• To quantify and compare key arachidonic acid metabolites in rat and mouse lungs.

Main Methods:

• Lung extracts from rats and mice were analyzed using liquid chromatography tandem mass spectrometry.
• The method was optimized for simultaneous separation and rapid quantification of major hydroxyeicosatetraenoic acids (HETEs) and prostaglandins (PGs).

Main Results:

• Basal levels of major eicosanoids, including 5-HETE, 8-HETE, 12-HETE, 15-HETE, PGE2, PGI2, and isoprostanes, were significantly higher in mouse lungs compared to rat lungs.
• The prostacyclin (PGI2) to thromboxane B2 (TXB2) ratio was elevated in mouse lungs relative to rat lungs.
• Significant differences in basal eicosanoid profiles were observed between rat and mouse lungs.

Conclusions:

• The distinct eicosanoid profiles, particularly the PGI2/TXB2 ratio, in rat and mouse lungs may contribute to interspecies variations in susceptibility to pulmonary hypertension.
• These findings highlight the role of specific arachidonic acid metabolites in regulating pulmonary vascular tone and disease development.